🍽️ khellin non-drug

AI Engines For more Details: PerplexityKagi LabsYou

  1. Bronchodilation: Khellin has been investigated for its bronchodilatory effects, which means it may help widen the airways in the lungs. This property has led to its exploration in the treatment of respiratory conditions such as asthma.

  2. Antispasmodic: Khellin has been reported to possess antispasmodic properties, which could make it useful in alleviating muscle spasms or cramps.

  3. Vasodilation: Some studies suggest that khellin may have vasodilatory effects, meaning it can widen blood vessels. This property could potentially be beneficial in conditions where improved blood flow is desired, such as certain cardiovascular conditions.

  4. Phototherapy: Khellin has been studied for its photosensitizing properties, particularly in combination with ultraviolet A (UVA) light. This combination, known as PUVA therapy (psoralen combined with ultraviolet A), has been used in the treatment of certain skin conditions like psoriasis and vitiligo.

  5. Antimicrobial: There is some evidence to suggest that khellin may possess antimicrobial properties, although further research is needed to fully understand its potential in this area.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of khellin non-drug On Probiotics

Rank Probiotic Impact

Bacteria Impacted by khellin non-drug

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Ruminococcus genus Decreases 👪 Source Study
Agathobacter genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Clostridioides genus Decreases 👪 Source Study
Mediterraneibacter genus Decreases 👪 Source Study
Coprococcus genus Decreases 👪 Source Study
Eggerthella genus Decreases 👪 Source Study
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
Ruminococcus bromii species Decreases 📓 Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Agathobacter rectalis species Decreases 📓 Source Study
Roseburia hominis species Decreases 📓 Source Study
Clostridioides difficile species Decreases 📓 Source Study Colitis
[Ruminococcus] torques species Decreases 📓 Source Study
Coprococcus comes species Decreases 📓 Source Study
Eggerthella lenta species Decreases 📓 Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of khellin non-drug on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.3 0 0
Age-Related Macular Degeneration and Glaucoma 0 0
Allergies 0.1 0.4 -3
Allergy to milk products 0.2 0.2
Alzheimer's disease 0.2 0.5 -1.5
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0 0.2 0
Ankylosing spondylitis 0.2 -0.2
Anorexia Nervosa 0.3 -0.3
Asthma 0 0 0
Atherosclerosis 0.2 0 0
Atrial fibrillation 0.2 0.2
Autism 0.4 0.3 0.33
Bipolar Disorder 0.2 0.3 -0.5
Brain Trauma 0 0
Carcinoma 0.2 0.2 0
Celiac Disease 0.2 -0.2
Cerebral Palsy 0.2 -0.2
Chronic Fatigue Syndrome 0.8 0.1 7
Chronic Kidney Disease 0 0.1 0
Chronic Lyme 0 0
Chronic Obstructive Pulmonary Disease (COPD) 0 0
Coagulation / Micro clot triggering bacteria 0.2 -0.2
Colorectal Cancer 0.2 0 0
Constipation 0 0
Coronary artery disease 0.2 0 0
COVID-19 0.2 0.8 -3
Crohn's Disease 0.3 0.3 0
cystic fibrosis 0 0
deep vein thrombosis 0.2 -0.2
Depression 0.4 0.4 0
Endometriosis 0 0.2 0
Fibromyalgia 0 0 0
Functional constipation / chronic idiopathic constipation 0.2 0.1 1
gallstone disease (gsd) 0.2 0 0
Generalized anxiety disorder 0 0
Gout 0 0
Graves' disease 0 0
Hashimoto's thyroiditis 0.1 0.1
High Histamine/low DAO 0 0.2 0
hypertension (High Blood Pressure 0.2 0.1 1
Hypothyroidism 0 0
Inflammatory Bowel Disease 0 0.8 0
Insomnia 0 0
Intelligence 0 0
Intracranial aneurysms 0.2 0.2
Irritable Bowel Syndrome 0.2 0 0
Liver Cirrhosis 0.2 0.2 0
Long COVID 0.1 0.7 -6
Low bone mineral density 0 0
Lung Cancer 0.2 -0.2
Mast Cell Issues / mastitis 0.2 -0.2
ME/CFS with IBS 0 0
ME/CFS without IBS 0.1 0.1
Metabolic Syndrome 0.3 0.3 0
Mood Disorders 0.6 0.4 0.5
Multiple Sclerosis 0.2 0.3 -0.5
Multiple system atrophy (MSA) 0.1 0.2 -1
neuropathic pain 0.1 -0.1
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.3 -0.3
Obesity 0.4 0.2 1
obsessive-compulsive disorder 0.5 0.1 4
Osteoarthritis 0.2 -0.2
Osteoporosis 0.2 0.2
Parkinson's Disease 0 0.3 0
Polycystic ovary syndrome 0.2 0.5 -1.5
Postural orthostatic tachycardia syndrome 0 0
Psoriasis 0.2 0 0
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.3 0 0
Rosacea 0.3 0 0
Schizophrenia 0.2 0.2 0
scoliosis 0 0.2 0
Sjögren syndrome 0 0
Sleep Apnea 0.2 0 0
Slow gastric motility / Gastroparesis 0.2 0.2
Stress / posttraumatic stress disorder 0 0.1 0
Systemic Lupus Erythematosus 0 0.2 0
Tic Disorder 0.2 0.2
Type 1 Diabetes 0.2 0 0
Type 2 Diabetes 0.3 0.2 0.5
Ulcerative colitis 0 0
Unhealthy Ageing 0.1 0.1 0

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results. < p > Explanations / Info / Descriptions are influenced by < a href = "/home/sources" target = "_blank" > Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction. < p style = "font-size" .4em"> Copyright 2016 - 2024 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA < br /> Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. < br />< em > Caveat emptor: Analysis and suggestions are based on modelling(and thus < i > infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions / Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant or equivalent EU laws. [44.213.60 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [44.213.60 ]